DK508885A - Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf - Google Patents

Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf Download PDF

Info

Publication number
DK508885A
DK508885A DK508885A DK508885A DK508885A DK 508885 A DK508885 A DK 508885A DK 508885 A DK508885 A DK 508885A DK 508885 A DK508885 A DK 508885A DK 508885 A DK508885 A DK 508885A
Authority
DK
Denmark
Prior art keywords
antibiotecum
estery
derivatives
preparing
procedure
Prior art date
Application number
DK508885A
Other languages
English (en)
Other versions
DK508885D0 (da
Inventor
A Malabarba
A Magni
P Strazzolini
B Cavalleri
A Trani
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK508885D0 publication Critical patent/DK508885D0/da
Publication of DK508885A publication Critical patent/DK508885A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Catalysts (AREA)
DK508885A 1984-11-13 1985-11-05 Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf DK508885A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848428619A GB8428619D0 (en) 1984-11-13 1984-11-13 Derivatives of antibiotic l 17046

Publications (2)

Publication Number Publication Date
DK508885D0 DK508885D0 (da) 1985-11-05
DK508885A true DK508885A (da) 1986-05-14

Family

ID=10569641

Family Applications (1)

Application Number Title Priority Date Filing Date
DK508885A DK508885A (da) 1984-11-13 1985-11-05 Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf

Country Status (13)

Country Link
US (1) US4661470A (da)
EP (1) EP0182157B1 (da)
JP (1) JPS61122300A (da)
KR (1) KR860004076A (da)
AT (1) ATE78261T1 (da)
CA (1) CA1250098A (da)
DE (1) DE3586344T2 (da)
DK (1) DK508885A (da)
ES (1) ES8704964A1 (da)
GB (1) GB8428619D0 (da)
HU (1) HU196228B (da)
IL (1) IL76996A0 (da)
ZA (1) ZA858449B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT86457B (pt) * 1986-12-30 1990-11-20 Smithkline Beecham Corp Processo para a preparacao de glicopeptidos glicosilados e de composicoes que os contem
US4882313A (en) * 1987-07-31 1989-11-21 Smithkline Beckman Corporation Carboxamide derivatives of glycopeptides
GB8808658D0 (en) * 1988-04-13 1988-05-18 Lepetit Spa Aglycons of a/16686 antibiotics
US5606036A (en) * 1991-03-27 1997-02-25 Gruppo Lepetit Spa Antibiotic A 40926 ester derivatives
MY123217A (en) * 1998-12-23 2006-05-31 Theravance Inc Glycopeptide derivatives and pharmaceutical compositions containing the same
DE69908819T2 (de) * 1998-12-23 2004-05-06 Theravance, Inc., South San Francisco Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
US7119061B2 (en) * 2002-11-18 2006-10-10 Vicuron Pharmaceuticals, Inc. Dalbavancin compositions for treatment of bacterial infections
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
AU2003299561A1 (en) * 2002-11-18 2004-06-15 Vicuron Pharmaceuticals Inc. Compositions and methods for treating bacterial infections with protein-dalbavancin complexes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64486A (en) * 1980-12-18 1985-01-31 Lilly Co Eli Antibiotic a-4696 factor g,its preparation and use as feed supplement for ruminant animals
FI73697C (fi) * 1982-06-08 1987-11-09 Lepetit Spa Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2.
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
GB8415092D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Ester derivatives

Also Published As

Publication number Publication date
GB8428619D0 (en) 1984-12-19
ES8704964A1 (es) 1987-04-16
US4661470A (en) 1987-04-28
JPS61122300A (ja) 1986-06-10
EP0182157A3 (en) 1987-12-09
DE3586344D1 (de) 1992-08-20
IL76996A0 (en) 1986-04-29
HU196228B (en) 1988-10-28
HUT41053A (en) 1987-03-30
EP0182157B1 (en) 1992-07-15
ATE78261T1 (de) 1992-08-15
DK508885D0 (da) 1985-11-05
ES548789A0 (es) 1987-04-16
CA1250098A (en) 1989-02-14
EP0182157A2 (en) 1986-05-28
DE3586344T2 (de) 1993-03-11
KR860004076A (ko) 1986-06-16
ZA858449B (en) 1986-08-27

Similar Documents

Publication Publication Date Title
NO166131C (no) Analogifremgangsmaate for fremstilling av s(-)-pyridobenzoksazinforbindelser.
GB2210747B (en) Linear amplification of signals
NO902834D0 (no) Regulering av mikrobiell vekst med lantibiotiske/lysosymformuleringer.
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
SE8206731D0 (sv) Ester- och amid-derivat av 13,14-didehydro-prostaglandiner
NO890121D0 (no) Forsterkning av optiske signaler.
DK90182A (da) Biologisk aktive amidderivater
FI863687A0 (fi) Amider av teikoplaninfoereningar.
TR24474A (tr) Dijital sinyallerin nakledilmesine mahsus disper- sif linear veya yaklasik olara
IT8022585A0 (it) Procedimento di produzione di miscele di antibiotici dalla coltivazione di aspergillus nidulans varieta'roseus
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
DK508885A (da) Esterderivat af antibiotekum l 17046 og fremgangsmaade til fremstilling deraf
FI850781A0 (fi) Foerfarande foer framstaellning av av l-karnitin pao mikrobiologiskt saett.
IT7849266A0 (it) Composti per il controllo della crescita microbica
ES466037A1 (es) Un procedimiento para preparar derivados de oleandomicina.
ES2079724T3 (es) Nuevos compuestos antibioticos y su produccion.
FI851306A7 (fi) Kefalosporiinijohdannaisten estereitä.
ES8107309A1 (es) Un procedimiento de produccion de derivados de 7 -metoxice- falosporina
ES454009A1 (es) Un procedimiento para la preparacion de nuevos esteres de derivados del acido clavulanico.
IT1062486B (it) Procedimento per la trasmissione numerica di segnali video codificati
FI843741A0 (fi) Anordning foer reglering av glappet i en kuggvaexel.
SU1448442A1 (ru) Препарат для лечения и профилактики вольфартиоза сельскохозяйственных животных
SU1417444A1 (ru) 2,4-Дифенил-3(4-ацетокси-4-метилгексин-2-ил)-3-азабицикло [3,3,1]нонан-9-он, проявляющий противовоспалительную активность

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment